CLINICAL_TRIALS trial_result · 2024-08-05

Clinical Trial Update: A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis [Phase 1]

This update reports the completion of a Phase 1 safety study of B244 topical spray in pediatric patients with atopic dermatitis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: AOBiome LLC | Conditions: Eczema, Atopic Dermatitis | Phase 1 | Status: COMPLETED | Results posted: 2024-08-05